Where does Curiteva, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Curiteva, Inc. ranks #13,934 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Curiteva, Inc. hold?

Curiteva, Inc. holds 21 US utility patents granted between 2020 and 2025, spanning 13 technology areas.

What is Curiteva, Inc.'s Innovation Score?

Curiteva, Inc. has an Innovation Score of 33.4 out of 100 (44th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Curiteva, Inc. focus on?

Curiteva, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 6 patents, ranking #2,680 of 7,127 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Curiteva, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Curiteva, Inc..

What does claim depth mean for Curiteva, Inc.'s patents?

Curiteva, Inc.'s patents average 8.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Curiteva, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Curiteva, Inc.

USPTO PatentsView assignee record - 21 granted patents across 13 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Curiteva ranks #13,934 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 13 technology areas.

#13,934
of 49,997 US assignees by volume: 44th percentile
by Innovation Score (33.4/100): 8.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R13934 · US Corporation #13,934 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 21 grants
MID-PACK #13,934/49,997
PHOTO-FINISH Control Module
CPC-FOCUS A61B · 13 areas
INNOV-THIN 33.4/100
CLAIMS-PAR 8.9 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Control Module, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Curiteva’s 33.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (32%) Velocity 4.7 pts (14%) Breadth 12.7 pts (38%) Claim depth 5.3 pts (16%)

Qualcomm Incorporated · highest

85
Curiteva · this assignee

33
Novira Therapeutics · near

33
Q3 Medical Devices · near

33
Evga · near

33
Kirintec · near

33
3D Lighting… · lowest

7

What this shows Curiteva's Innovation Score is 33.4/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Curiteva?

Each dot is one of Curiteva’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Curiteva’s own 8.9 claims/patent is at or below the 11.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Curiteva vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Curiteva's grants concentrate

Curiteva, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 28.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (8 grants) versus a trough of 1 in 2023. By volume, Curiteva sits between Control Module, Inc. and Daicel-evonik Ltd..

Curiteva's three-year grant acceleration

Curiteva, Inc. shows 7 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Control Module

21
Cornell Pump

21
Cosmed Pharmaceut…

21
Crystalvue Medical

21
Custom-pak

21
Cytek Biosciences

21
DA International

21
Daicel-evonik

21
Curiteva ◀

21

What this shows Curiteva holds 21 patents at rank #13,935, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Curiteva

By rank, the assignees closest to #13,935 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Curiteva's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Curiteva, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Curiteva ranks #2,680 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (33 here).

Q3 Medical Devices Limited 33 Novira Therapeutics, Inc. 33 Evga Corporation 33 Kirintec Limited 33

Curiteva's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 44th percentile higher than 44% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Curiteva, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	8	38.1%
2021	2	9.5%
2022	5	23.8%
2023	1	4.8%
2024	1	4.8%
2025partial year	4	19.0%

Which technologies does Curiteva, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 6

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 4

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

G06V - Image OR Video Recognition OR Understanding 3

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 3

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 3

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 3

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 3

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 3

G06T - Image Data Processing OR Generation, IN General 3

F16B - Devices FOR Fastening OR Securing Constructional Elements OR Machine Parts Together, e.g. Nails, Bolts, Circlips, Clamps, Clips OR WEDGES; Joints OR Jointing 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Curiteva, Inc.'s patent record in context - here's where to go next.

Curiteva, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 28.6% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #13,934 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Curiteva, Inc. against Control Module, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.